Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
55.30 x 1 60.98 x 10
Post-market by (Cboe BZX)
59.17 +0.35 (+0.60%) 04/17/25 [NASDAQ]
55.30 x 1 60.98 x 10
Post-market 59.17 unch (unch) 16:26 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
58.00
Day High
59.62
Open 58.44
Previous Close 58.82 58.82
Volume 1,247,100 1,247,100
Avg Vol 2,032,985 2,032,985
Stochastic %K 32.88% 32.88%
Weighted Alpha -34.33 -34.33
5-Day Change +2.85 (+5.06%) +2.85 (+5.06%)
52-Week Range 52.93 - 94.85 52.93 - 94.85
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,289,872
  • Shares Outstanding, K 190,804
  • Annual Sales, $ 2,854 M
  • Annual Income, $ 426,860 K
  • EBIT $ 484 M
  • EBITDA $ 572 M
  • 60-Month Beta 0.30
  • Price/Sales 3.93
  • Price/Cash Flow 18.12
  • Price/Book 1.98

Options Overview Details

View History
  • Implied Volatility 38.94% ( -6.14%)
  • Historical Volatility 49.70%
  • IV Percentile 92%
  • IV Rank 49.52%
  • IV High 55.63% on 04/10/25
  • IV Low 22.57% on 04/26/24
  • Put/Call Vol Ratio 0.42
  • Today's Volume 638
  • Volume Avg (30-Day) 1,408
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 40,318
  • Open Int (30-Day) 36,627

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.75
  • Number of Estimates 10
  • High Estimate 0.88
  • Low Estimate 0.49
  • Prior Year 0.49
  • Growth Rate Est. (year over year) +53.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.93 +11.79%
on 04/09/25
Period Open: 71.55
73.18 -19.14%
on 03/27/25
-12.38 (-17.30%)
since 03/17/25
3-Month
52.93 +11.79%
on 04/09/25
Period Open: 61.53
73.51 -19.51%
on 03/07/25
-2.36 (-3.84%)
since 01/17/25
52-Week
52.93 +11.79%
on 04/09/25
Period Open: 90.47
94.85 -37.62%
on 08/20/24
-31.30 (-34.60%)
since 04/17/24

Most Recent Stories

More News
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

SRPT : 53.79 (-0.28%)
BMRN : 59.17 (+0.60%)
ABBV : 172.99 (+0.76%)
MRNA : 24.72 (-1.89%)
AMGN : 277.29 (-1.89%)
6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility

Though the stock market is still historically pricey, a few phenomenal bargains have cropped up.

COMP : 7.29 (-3.95%)
PUBM : 9.13 (+12.16%)
INTC : 18.93 (-1.56%)
BMRN : 59.17 (+0.60%)
FSLY : 5.39 (+1.32%)
SIRI : 20.32 (+1.20%)
PFE : 22.14 (+0.45%)
Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On

The American trade structure is witnessing a transformative shift, thanks to the Trump administration’s sweeping new tariff policy. Within the healthcare industry, the impact seems to be complex and...

UHS : 174.80 (+0.66%)
ABT : 130.98 (+0.99%)
BMRN : 59.17 (+0.60%)
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

BMRN : 59.17 (+0.60%)
VRTX : 489.10 (+0.66%)
MRNA : 24.72 (-1.89%)
UTHR : 284.73 (-0.16%)
BIIB : 118.61 (+2.88%)
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

SRPT : 53.79 (-0.28%)
BMRN : 59.17 (+0.60%)
VRTX : 489.10 (+0.66%)
MRNA : 24.72 (-1.89%)
AMGN : 277.29 (-1.89%)
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction

Stock market downturns are traditionally the ideal time to go shopping for bargains.

PYPL : 61.00 (+1.26%)
COMP : 7.29 (-3.95%)
GOOGL : 151.16 (-1.42%)
GOOG : 153.36 (-1.38%)
$NASX : 16,286.45 (-0.13%)
TTD : 50.26 (+3.74%)
$SPX : 5,282.70 (unch)
BMRN : 59.17 (+0.60%)
AMZN : 172.61 (-0.99%)
2 Reasons to Like BMRN (and 1 Not So Much)

2 Reasons to Like BMRN (and 1 Not So Much)

BMRN : 59.17 (+0.60%)
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

SRPT : 53.79 (-0.28%)
BMRN : 59.17 (+0.60%)
ABBV : 172.99 (+0.76%)
MRNA : 24.72 (-1.89%)
BIIB : 118.61 (+2.88%)
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

SRPT : 53.79 (-0.28%)
BMRN : 59.17 (+0.60%)
GILD : 104.54 (-0.32%)
MRNA : 24.72 (-1.89%)
AMGN : 277.29 (-1.89%)
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

BMRN : 59.17 (+0.60%)
VRTX : 489.10 (+0.66%)
MRNA : 24.72 (-1.89%)
UTHR : 284.73 (-0.16%)
BIIB : 118.61 (+2.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 61.48
2nd Resistance Point 60.55
1st Resistance Point 59.86
Last Price 59.17
1st Support Level 58.24
2nd Support Level 57.31
3rd Support Level 56.62

See More

52-Week High 94.85
Fibonacci 61.8% 78.84
Fibonacci 50% 73.89
Fibonacci 38.2% 68.94
Last Price 59.17
52-Week Low 52.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro